Kate Farms, a supplement company founded in 2012 for pediatric tube feeding, redesigned its product line with GLP-1 users in mind and expanded its presence in Walmart, according to Modern Retail. The brand repositioned clinical nutrition for the 17 million Americans on semaglutide drugs who struggle to meet protein and nutrient targets while eating less.
The company shifted packaging language from medical terminology to lifestyle benefits. Labels now emphasize protein density per ounce, quick absorption, and portion control rather than clinical feeding protocols. Bottle sizes moved from hospital-standard formats to 8-ounce ready-to-drink servings that fit GLP-1 users' reduced stomach capacity. The reformulated messaging tested in focus groups with Ozempic and Wegovy patients who reported difficulty consuming solid meals.
This worked because GLP-1 users represent a consumer segment with documented purchasing intent but no dedicated shelf presence. Walmart's buyer resistance to niche medical nutrition evaporated when Kate Farms presented the redesign as a mass-market wellness play targeting a fast-growing demographic. The retailer sees GLP-1 adoption accelerating in its core customer base and needed shelf solutions beyond protein powder. By framing the same clinical formula as a lifestyle product for appetite-suppressed consumers, Kate Farms converted a specialty medical SKU into a general wellness item that justified broader distribution.
The underlying mechanism: retailers expand shelf space when a supplier translates an emerging health behavior into a product they already understand. Walmart knows ready-to-drink nutrition. It did not know how to merchandise tube feeding. Kate Farms kept the formula, changed the customer story, and the buyer saw a protein beverage for a named consumer need.
A small physical-product brand runs this play by identifying one documented consumer behavior change in your category, then repackaging your existing product to serve it. If you sell hydration supplements, GLP-1 users need electrolytes because they drink less. If you sell portion-controlled snacks, they need calorie-dense options in small servings. Start with your current formula. Write new front-of-pack copy that names the behavior: "For reduced-appetite nutrition" or "High-protein for smaller meals." Test that language in a $500 Facebook ad campaign targeting GLP-1 support groups. Measure click-through against your current packaging. If the new framing outperforms by 20%+, produce a limited SKU run with the revised label and pitch it to one regional retailer as a test. Present the behavior data, the consumer language that tested, and the specific shelf it displaces. You are not inventing a product. You are renaming the job it does for a customer the retailer already wants.
The broader pattern: mass retailers will take a risk on a reformulated story before they take a risk on a new brand. If your product solves a problem created by a macro health trend, your fastest path to new doors is packaging that makes the solution obvious to a buyer who has thirty seconds to decide.